-
Surge in Compensation: Lilly CEO's Annual Salary Reaches $26.6 Million
In a remarkable development, the CEO of Eli Lilly and Company, David Ricks, has witnessed a substantial increase in his annual salary, soaring to an i...
2024-03-27 15:48 -
Hansoh Pharmaceutical Enters Reaping Season with Over 10 Billion Yuan in Revenue, Innovative Product...
Hansoh Pharmaceutical, a renowned pharmaceutical company, has recently announced its remarkable performance for the year 2023.
2024-03-27 15:45 -
Mabwell Biotech's Expansion into South Asia and Africa: A Bold Move
Mabwell Biotech, a leading pharmaceutical company, has recently made significant strides in expanding its presence in South Asia and Africa.
2024-03-27 15:41 -
The Price of Innovation: Lessons Learned and the Art of Cutting Losses
In the world of innovative pharmaceuticals, pausing doesn't equate to failure; it signifies wisdom. In this high-stakes domain, taking the time to ref...
2024-03-27 14:57 -
Fosun Pharma Achieves Impressive Growth with Revenue of 41.4 Billion Yuan in 2023
Fosun Pharma, a leading pharmaceutical company, has reported remarkable financial results for the year 2023. With a strong focus on innovation and glo...
2024-03-27 14:55 -
AbbieVie Escapes Its 'Curse': The Unfinished Story of FRα ADC
AbbieVie, a prominent player in the field of Antibody-Drug Conjugates (ADCs), has finally proven itself by successfully overcoming its challenges.
2024-03-26 17:12 -
Transformative Profits Unleashed by Versatile Innovative Pharmaceutical Companies
In the realm of pharmaceutical innovation, a new wave of companies is emerging, demonstrating remarkable profitability and groundbreaking advancements...
2024-03-26 17:09 -
Remarkable Surge: WuXi Biologics's Revenue and Profit Skyrocket by Over 110% in 2023
In a stunning display of financial prowess, WuXi Biologics, a leading global contract research, development, and manufacturing organization (CRDMO) fo...
2024-03-26 17:06 -
Pharma Giants Retreat: Another Major Player Bows Out of the IBD Race
This time, it is Japanese company Sosei Group Corporation that has announced the regaining of full ownership of HTL0027477 (formerly GSK4381406) from ...
2024-03-26 17:03 -
Breakthrough Deal: AriBio Secures $770 Million for Exclusive Marketing Rights of Alzheimer's Disease...
In a groundbreaking agreement, AriBio has announced the acquisition of exclusive marketing rights for AR1001, a potential treatment for early-stage Al...
2024-03-26 17:02
Hot News
- BASF’s Big Restructuring: Cut... Sep 01, 2025
- DuPont Bids Farewell to Its Ar... Sep 02, 2025
- Glenmark Recalls Over 110000 B... Aug 24, 2025
- FDA Clears Sanofi’s Wayrilz (... Aug 31, 2025
- Wanhua Chemical Boosts TDI Cap... Aug 24, 2025
Related Products